FULC
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024
时间:2024-11-13 20:00:03 市场: 美股 综合
Fulcrum Therapeutics Inc - Expects to Incur One-Time Costs of About $2.0 Mln in Connection With This Workforce Reduction
时间:2024-09-25 04:09:41 市场: 美股 综合
Fulcrum Therapeutics Inc: Plan to Reduce Co's Workforce From 80 to 51 Full-Time Employees
时间:2024-09-25 04:09:41 市场: 美股 综合
Fulcrum Therapeutics Shares Down 3% Premarket After 61% Drop in Previous Session
时间:2024-09-13 18:21:54 市场: 美股 综合
Fulcrum Therapeutics Inc : H.c. Wainwright Cuts to Neutral From Buy
时间:2024-09-13 18:14:30 市场: 美股 综合
Fulcrum Therapeutics Inc : Leerink Partners Cuts to Market Perform From Outperform
时间:2024-09-13 13:55:21 市场: 美股 综合
Fulcrum Therapeutics Inc : Piper Sandler Cuts Target Price to $6 From $16
时间:2024-09-12 22:10:56 市场: 美股 综合
Fulcrum Therapeutics Shares Fall 70% Premarket After Muscle Disorder Drug Fails in Late-Stage Study
时间:2024-09-12 19:42:20 市场: 综合 美股
Fulcrum Therapeutics Announces Topline Results From Phase 3 Reach Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (Fshd)
时间:2024-09-12 18:55:00 市场: 美股 综合